CXA champions wellness
March 15 2019 by Nick Ferguson
-
US exposures, climate change, pricing challenges weigh on APAC casualty underwriters
- November 15
The casualty market faces challenges in predicting risks due to global interconnectedness and emerging threats like PFAS and cyber.
-
Market consolidation crucial for APAC’s maturing economies: AM Best’s Carter
- November 14
Regulators are looking at capital reforms to drive consolidation, but the markets have yet to see the impact, says the rating agency’s APAC managing director.
-
SIRC: Reinsurers look to consolidate underwriting gains while tapping into fast-growing APAC
- November 11
As renewals conference season draws to a close with the Singapore event, IAN brings you the reinsurance gather's key takeaways and what they mean for upcoming renewals.
-
Cyber markets look to APAC for growth as market continues to soften
- November 8
As cyber insurance premiums are set to soar to US$20bn by 2026, the role of reinsurers and the importance of cyber hygiene in shaping the future of the market are becoming even more critical.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
